BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38457490)

  • 1. Legacy of a magic gene-
    OBrien SJ
    Proc Natl Acad Sci U S A; 2024 Mar; 121(12):e2321907121. PubMed ID: 38457490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
    Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
    J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons.
    Hummel S; Schmidt D; Kremeyer B; Herrmann B; Oppermann M
    Genes Immun; 2005 Jun; 6(4):371-4. PubMed ID: 15815693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
    Smith MW; Dean M; Carrington M; Winkler C; Huttley GA; Lomb DA; Goedert JJ; O'Brien TR; Jacobson LP; Kaslow R; Buchbinder S; Vittinghoff E; Vlahov D; Hoots K; Hilgartner MW; O'Brien SJ
    Science; 1997 Aug; 277(5328):959-65. PubMed ID: 9252328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug users.
    Alvarez V; López-Larrea C; Coto E
    Hum Genet; 1998 Apr; 102(4):483-6. PubMed ID: 9600249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ancient DNA Investigation of a Medieval German Cemetery Confirms Long-Term Stability of CCR5-Δ32 Allele Frequencies in Central Europe.
    Bouwman A; Shved N; Akgül G; Rühli F; Warinner C
    Hum Biol; 2017 Apr; 89(2):119-124. PubMed ID: 29299966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 protecting CCR5-Delta32 allele in medieval Poland.
    Zawicki P; Witas HW
    Infect Genet Evol; 2008 Mar; 8(2):146-51. PubMed ID: 18162443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.
    Li C; Yan YP; Shieh B; Lee CM; Lin RY; Chen YM
    J Formos Med Assoc; 1997 Dec; 96(12):979-84. PubMed ID: 9444918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?
    Faure E; Royer-Carenzi M
    Infect Genet Evol; 2008 Dec; 8(6):864-74. PubMed ID: 18790087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV.
    Sullivan AD; Wigginton J; Kirschner D
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10214-9. PubMed ID: 11517319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of the 32 bp deletion in the CCR5 chemokine receptor gene in people from Moscow, infected with HIV-1].
    Shadrina MI; Kapylov VM; Miloserdova OV; Slominskiĭ PA; Limborskaia SA
    Genetika; 2000 May; 36(5):718-20. PubMed ID: 10867893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic acceleration of AIDS progression by a promoter variant of CCR5.
    Martin MP; Dean M; Smith MW; Winkler C; Gerrard B; Michael NL; Lee B; Doms RW; Margolick J; Buchbinder S; Goedert JJ; O'Brien TR; Hilgartner MW; Vlahov D; O'Brien SJ; Carrington M
    Science; 1998 Dec; 282(5395):1907-11. PubMed ID: 9836644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.
    Zimmerman PA; Buckler-White A; Alkhatib G; Spalding T; Kubofcik J; Combadiere C; Weissman D; Cohen O; Rubbert A; Lam G; Vaccarezza M; Kennedy PE; Kumaraswami V; Giorgi JV; Detels R; Hunter J; Chopek M; Berger EA; Fauci AS; Nutman TB; Murphy PM
    Mol Med; 1997 Jan; 3(1):23-36. PubMed ID: 9132277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.
    Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wąsik TJ
    AIDS Rev; 2017 Dec; 19(4):219-230. PubMed ID: 28534889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.
    Kamkamidze G; Capoulade-Metay C; Butsashvili M; Dudoit Y; Chubinishvili O; Debre P; Theodorou L
    Georgian Med News; 2005 Jan; (118):74-9. PubMed ID: 15821335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the CCR5∆32 frequency in Emiratis and Tunisians and the screening of the CCR5 gene for novel alleles in Emiratis.
    Al-Jaberi SA; Ben-Salem S; Messedi M; Ayadi F; Al-Gazali L; Ali BR
    Gene; 2013 Oct; 529(1):113-8. PubMed ID: 23933274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon.
    Nkenfou CN; Mekue LC; Nana CT; Kuiate JR
    BMC Res Notes; 2013 Jul; 6():288. PubMed ID: 23880174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population.
    Donyavi T; Bokharaei-Salim F; Nahand JS; Garshasbi S; Esghaei M; Sadeghi M; Jamshidi S; Khanaliha K
    J Med Virol; 2020 Aug; 92(8):1158-1164. PubMed ID: 31854469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.
    Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
    Gastroenterology; 2002 Jun; 122(7):1721-8. PubMed ID: 12055576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.